Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

FDA expands HUD designation for Ortec's Composite Cultured Skin

Aug. 25, 1999

Two new RAR antagonists emerge from retinoid research program at Bristol-Myers Squibb

Aug. 24, 1999

QLT begins phase II trial for psoriasis treatment

Aug. 24, 1999

L'Oreal compounds prevent skin aging in experimental models

Aug. 23, 1999

Zenyaku Kogyo will develop and market novel psoriasis treatment in Japan

Aug. 20, 1999

Gliatech's IDE for ADCON-L approved by FDA

Aug. 20, 1999

IL-8 antagonists with broad therapeutic potential synthesized at SmithKline Beecham

Aug. 16, 1999

Welsh academic team studies inhibitors of retinoic acid metabolism for dermatology applications

Aug. 12, 1999

Antiallergic quinoline compounds prepared and tested by Dainippon Ink & Chemicals

Aug. 11, 1999

Fujisawa announced setback in launch data for Protopic

Aug. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...